Search research articles
Contact Us
Filters
Showing results (41-50 of 61) with videos related to
Page
of 7
Sort By:
Oral Oncology
|
April 10, 2020
Impact of cumulative cisplatin dose and adjuvant chemotherapy in locally-advanced nasopharyngeal carcinoma treated with definitive chemoradiotherapy
Marc Oliva, Shao Hui Huang, Rachel Taylor, et al.
Frontiers in Oncology
|
August 8, 2022
Paclitaxel Plus Cetuximab as Induction Chemotherapy for Patients With Locoregionally Advanced Head and Neck Squamous Cell Carcinoma Unfit for Cisplatin-Based Chemotherapy
Juan A Marín-Jiménez, Marc Oliva, Paloma Peinado Martín, et al.
Nature Communications
|
December 10, 2024
Enhanced warming of European mountain permafrost in the early 21st century
Jeannette Noetzli, Ketil Isaksen, Jamie Barnett, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 23, 2019
Impact of cisplatin dose and smoking pack-years in human papillomavirus-positive oropharyngeal squamous cell carcinoma treated with chemoradiotherapy
Marc Oliva, Shao Hui Huang, Wei Xu, et al.
British Journal of Cancer
|
May 7, 2024
Prospective manipulation of the gut microbiome with microbial ecosystem therapeutic 4 (MET4) in HPV-related locoregionally-advanced oropharyngeal cancer squamous cell carcinoma (LA-OPSCC) undergoing primary chemoradiation: ROMA2 study
Marc Oliva, Alya Heirali, Geoffrey Watson, et al.
Journal for Immunotherapy of Cancer
|
September 8, 2025
Randomized clinical efficacy and safety study of peltopepimut-S plus cemiplimab compared to cemiplimab alone in patients with recurrent/metastatic HPV16-positive head and neck cancer
Caroline Even, Kevin J Harrington, Erminia Massarelli, et al.
British Journal of Cancer
|
March 22, 2021
Transitions in oral and gut microbiome of HPV+ oropharyngeal squamous cell carcinoma following definitive chemoradiotherapy (ROMA LA-OPSCC study)
Marc Oliva, Pierre H H Schneeberger, Victor Rey, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 8, 2026
Phase I trial of intravenous VCN-01 oncolytic adenovirus and durvalumab in patients with head and neck metastatic squamous cell carcinoma refractory to immunotherapy
Maria Jove, Irene Braña, Marc Oliva, et al.
Oral Oncology
|
November 23, 2025
Subcutaneous amivantamab in recurrent/metastatic head and neck squamous cell cancer after disease progression on checkpoint inhibitor and chemotherapy: Preliminary results from the phase 1b/2 OrigAMI-4 study
Kevin J Harrington, Ari J Rosenberg, Muh-Hwa Yang, et al.
The Laryngoscope
|
August 26, 2025
Prognostic Factors in Sinonasal Cancers: A Multicenter Pooled Analysis
Milica Stefanovic, Alberto Hernando-Calvo, Jesus Brenes Castro, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 61) with videos related to
Sort By:
Page
of 7
Oral Oncology
|
April 10, 2020
Impact of cumulative cisplatin dose and adjuvant chemotherapy in locally-advanced nasopharyngeal carcinoma treated with definitive chemoradiotherapy
Marc Oliva, Shao Hui Huang, Rachel Taylor, et al.
Frontiers in Oncology
|
August 8, 2022
Paclitaxel Plus Cetuximab as Induction Chemotherapy for Patients With Locoregionally Advanced Head and Neck Squamous Cell Carcinoma Unfit for Cisplatin-Based Chemotherapy
Juan A Marín-Jiménez, Marc Oliva, Paloma Peinado Martín, et al.
Nature Communications
|
December 10, 2024
Enhanced warming of European mountain permafrost in the early 21st century
Jeannette Noetzli, Ketil Isaksen, Jamie Barnett, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 23, 2019
Impact of cisplatin dose and smoking pack-years in human papillomavirus-positive oropharyngeal squamous cell carcinoma treated with chemoradiotherapy
Marc Oliva, Shao Hui Huang, Wei Xu, et al.
British Journal of Cancer
|
May 7, 2024
Prospective manipulation of the gut microbiome with microbial ecosystem therapeutic 4 (MET4) in HPV-related locoregionally-advanced oropharyngeal cancer squamous cell carcinoma (LA-OPSCC) undergoing primary chemoradiation: ROMA2 study
Marc Oliva, Alya Heirali, Geoffrey Watson, et al.
Journal for Immunotherapy of Cancer
|
September 8, 2025
Randomized clinical efficacy and safety study of peltopepimut-S plus cemiplimab compared to cemiplimab alone in patients with recurrent/metastatic HPV16-positive head and neck cancer
Caroline Even, Kevin J Harrington, Erminia Massarelli, et al.
British Journal of Cancer
|
March 22, 2021
Transitions in oral and gut microbiome of HPV+ oropharyngeal squamous cell carcinoma following definitive chemoradiotherapy (ROMA LA-OPSCC study)
Marc Oliva, Pierre H H Schneeberger, Victor Rey, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 8, 2026
Phase I trial of intravenous VCN-01 oncolytic adenovirus and durvalumab in patients with head and neck metastatic squamous cell carcinoma refractory to immunotherapy
Maria Jove, Irene Braña, Marc Oliva, et al.
Oral Oncology
|
November 23, 2025
Subcutaneous amivantamab in recurrent/metastatic head and neck squamous cell cancer after disease progression on checkpoint inhibitor and chemotherapy: Preliminary results from the phase 1b/2 OrigAMI-4 study
Kevin J Harrington, Ari J Rosenberg, Muh-Hwa Yang, et al.
The Laryngoscope
|
August 26, 2025
Prognostic Factors in Sinonasal Cancers: A Multicenter Pooled Analysis
Milica Stefanovic, Alberto Hernando-Calvo, Jesus Brenes Castro, et al.
Page
of 7